Gene Im - Liver Transplantation | Mount Sinai

About Me

Dr. Gene Y Im is an Assistant Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai. He earned his B.A. from the University of California, Berkeley, graduating with honors. He completed his Internal Medicine residency and fellowship in Gastroenterology at Winthrop-University Hospital, the primary teaching affiliate for the SUNY Stony Brook School of Medicine. He then completed an advanced fellowship in Transplant Hepatology at the Mount Sinai Medical Center. He is currently the Associate Program Director of the Transplant Hepatology fellowship and RSS course director of the Division of Liver Diseases at Mount Sinai.

Dr. Im’s areas of clinical interest include cirrhosis, acute/chronic liver diseases, portal hypertension, liver biopsy, quality improvement, endoscopy, inpatient care of liver patients and liver transplantation.

His research program focuses on alcoholic hepatitis and liver disease, including early liver transplantation for alcoholic hepatitis, portal hypertension, liver biopsy and outcomes-based research.

Dr. Im is an UNOS-certified Liver Transplant physician and is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. He is also a member of the American Association for the Study of Liver Diseases.

Language

English

Position

ASSOCIATE PROFESSOR | Medicine, Liver Diseases

Hospital Affiliations

Mount Sinai Queens
The Mount Sinai Hospital

Research Topics

Addiction, Health Services Research, Hepatitis C Virus, Liver, Transplantation

Clinical Focus

Acute and Chronic Liver Failure
Alcoholic Liver Disease
Autoimmune Liver Disease
Benign Neoplasm
Chronic Liver Disease
Cirrhosis
Colon Polypectomy
Colonoscopy
End - Stage Liver Disease Management

Education

MD, New York Medical College

Residency, Internal Medicine

Winthrop-University Hospital

Fellowship, Gastroenterology

Winthrop-University Hospital

Fellowship, Transplant Hepatology

Mount Sinai Hospital

Certifications

American Board of Internal Medicine

Research

Early liver transplantation for severe alcoholic hepatitis has recently been demonstrated to be a feasible and effective therapy for highly selected patients who fail medical therapy and violate the so-called “6 month rule,” using a rigorous evaluation program. Here at Mount Sinai, we are leading the North American experience of early liver transplantation as a rescue therapy for selected patients with severe alcoholic hepatitis. Particular areas of interest include patient selection, outcomes, burden on organ supply and alcohol relapse. Translational collaborations are being planned with the Alcoholic Liver Disease Research Center at Mount Sinai to further elucidate the pathogenesis of alcoholic hepatitis. Future clinical trials to evaluate therapies with less side-effects, more targeted therapies or those aimed hepatic regeneration are needed.

Locations

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Healthfirst Medicare Advantage insurance: Effective 9/1/2024, Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.

RMTI Liver Disease5 East 98th Street, 12th Floor, New York, NY, 10029

RMTI Liver Transplantation5 East 98th Street, 12th Floor, New York, NY, 10029

RMTI Liver Disease - Queens25-20 30th Avenue, 4th Floor, Astoria, NY, 11102

RMTI Liver Transplantation - Queens25-20 30th Avenue, 4th Floor, Astoria, NY, 11102

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Publications:64

Selected Publications

View All Publications

Patient Experience Rating

The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.

Care Provider’s Explanation

4.9 out of 5

Care Provider’s Concern

5 out of 5

Likelihood to Recommend Care Provider

4.9 out of 5

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Im during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Novo Nordisk, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Gene Im, MD

Liver Transplantation

About Me

Language

Position

Hospital Affiliations

Research Topics

About Me

Language

Position

Hospital Affiliations

Research Topics

Clinical Focus

Video

Education

MD, New York Medical College

Residency, Internal Medicine

Fellowship, Gastroenterology

Fellowship, Transplant Hepatology

Certifications

American Board of Internal Medicine

Research

Locations

RMTI Liver Disease

RMTI Liver Transplantation

RMTI Liver Disease - Queens

RMTI Liver Transplantation - Queens

Insurance Information

Publications

Selected Publications

Patient Experience Rating

Care Provider’s Explanation

Care Provider’s Concern

Likelihood to Recommend Care Provider

Industry Relationships

Gene Im, MD

Liver Transplantation

About Me

Language

Position

Hospital Affiliations

Research Topics

About Me

Language

Position

Hospital Affiliations

Research Topics

Clinical Focus

Video

Education

MD, New York Medical College

Residency, Internal Medicine

Fellowship, Gastroenterology

Fellowship, Transplant Hepatology

Certifications

American Board of Internal Medicine

Research

Locations

RMTI Liver Disease

RMTI Liver Transplantation

RMTI Liver Disease - Queens

RMTI Liver Transplantation - Queens

Insurance Information

Publications

Selected Publications

Patient Experience Rating ?

Care Provider’s Explanation

Care Provider’s Concern

Likelihood to Recommend Care Provider

Industry Relationships

Patient Experience Rating